Patricia M. Millican

Patricia serves as Senior Vice President of Finance and Chief Accounting Officer, Metacrine, Inc. Mrs. Millican has over 15 years of finance experience in healthcare. Ms. Millican served as vice president of finance at Aragon Pharmaceuticals Inc. until its sale in August 2013 to Johnson & Johnson. Ms. Millican served as senior director and corporate controller for Zogenix, Inc., a publicly-traded specialty biotechnology company, from September 2009 to August 2012 and served as chief accounting officer for Metabasis Therapeutics, Inc., a publicly-traded biotechnology company, until its sale in 2010. Mrs. Millican’s experience also includes six years of financial management experience in other publicly-traded biotechnology companies such as Discovery Partners Int’l (currently Infinity Pharmaceuticals) and Nanogen Inc. She spent five years with the public accounting firm Deloitte, is a certified public accountant in the state of California and holds a B.S. in Accounting from the University of San Diego.